Roundtable: Clinical Lessons Learnt from RNA and ASO Approaches in the CNS
Time: 9:30 am
day: Day Two Whole
Details:
- Successfully proving clinically viable biodistribution and potential biomarkers
- Considerations when maintaining efficacy and safety for advanced CNS directed therapies
- Outlining experiences with regulatory bodies during clinical trials
